Men report 15 to 30 pounds lost over 3 to 6 months, with some losing significantly more
Genetic Variation in Lipid Metabolism and GLP-1 Response Variations in genes controlling lipid transport, apolipoprotein metabolism, and triglyceride synthesis influence how efficiently GLP-1 therapy reduces triglyceride levels
Morgenstern highlights a critical safety concern: when this physical weakness is paired with visual impairment from glaucoma or AMD, the risk of life-threatening falls increases exponentially
Lipid panel monitoring should occur at 8-12 weeks after GLP-1 initiation and periodically thereafter
Then it stalled
Sleep disturbances, including insomnia and excessive daytime sleepiness, afflict up to 80% of patients, managed through lactulose, melatonin, and cognitive behavioral therapies